| Views | |
|---|---|
| Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells | 251 |
| October 2025 | November 2025 | December 2025 | January 2026 | February 2026 | March 2026 | April 2026 | |
|---|---|---|---|---|---|---|---|
| Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells | 33 | 24 | 8 | 24 | 19 | 25 | 11 |
| Views | |
|---|---|
| 2022_Berlak_etal.pdf | 64 |
